Thryv Holdings recently saw its consensus analyst price target fall significantly, dropping from $19.50 to $13.00. This notable decline comes as experts reassess the company’s near-term prospects in ...

Thryv Holdings' stock recently saw its fair value estimate reaffirmed at $13.00 per share. This reflects stability in analysts’ core valuation despite ongoing transition challenges. Meanwhile, the ...

MONTREAL, Dec. 2, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited ...

MONTREAL, Nov. 19, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited ...

SARASOTA, Fla. (WWSB) - A Suncoast wellness provider has rebranded and expanded its services to focus on preventive health optimization. We Pellet is now known as Thryv Collective. The company said it ...

Get the latest news and real-time alerts from Thryv Holdings, Inc. (THRY) stock at Seeking Alpha.

Thryv Holdings, Inc. (THRY) related stocks - discover similar stocks and their valuation, compare dividends and return. Compare momentum and price performance.

Chart does not reflect overnight price.